Skip to main navigation
Skip to search
Skip to main content
Universidad Continental Home
Español
English
Search content at Universidad Continental
Home
Researchers
Research units
Projects
Research output
Prizes
Activities
Theses
Sobrevida del adenocarcinoma ductal de páncreas
Translated title of the contribution
:
Survival of patients with pancreatic ductal adenocarcinoma
Javier Targarona
, Luis Rivero
, Guillermo Coayla
, Gilbert Roman
, Diego Rivas
, Sebastián Legua
, Roberto Carrasco
Faculty of health sciences
Research output
:
Contribution to journal
›
Original Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Survival of patients with pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patient Survival
100%
Median Survival
100%
Pancreatic Ductal Adenocarcinoma
100%
Nine-level
60%
Carbohydrate Antigen 19-9 (CA19-9)
60%
Resective Surgery
40%
Neoadjuvant Chemotherapy
40%
Lima
20%
Peru
20%
Retrospective Cohort Study
20%
Epidemiological Factors
20%
Better Prognosis
20%
Radiological Findings
20%
January 2015
20%
Oncologic
20%
Survival Prognosis
20%
Oligometastatic Patients
20%
Resection
20%
Neoadjuvant Therapy
20%
Adjuvant Chemotherapy
20%
Locally Advanced Cancer
20%
Pancreatectomy
20%
Salvage Chemotherapy
20%
Overall Survival
20%
Resectable Tumors
20%
Metastatic Tumor
20%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Clinical Stage
66%
Neoadjuvant Chemotherapy
66%
Tumor
66%
Retrospective Cohort Study
33%
Radiological Finding
33%
Neoadjuvant Therapy
33%
Metastatic Carcinoma
33%
Adjuvant Chemotherapy
33%
Pancreatectomy
33%
Overall Survival
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Pancreas Adenocarcinoma
100%
Cohort Study
33%
Overall Survival
33%